Picture of Bioventus logo

BVS Bioventus News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapSuper Stock

Bioventus Inc reports results for the quarter ended in June - Earnings Summary

* Bioventus Inc  BVS.OQ  reported quarterly adjusted
earnings of
10 cents​​ per share for the quarter ended in June. The mean
expectation of five analysts for the quarter was for earnings of
16 cents per share.
    * Revenue rose 27.8% to $140.33 million from a year ago;
analysts
expected $138.33 million. 
    * Bioventus Inc's reported EPS for the quarter was a loss
of 11
cents​.
    * The mean earnings estimate of analysts had fallen by
about 12.4%
in the last three months.​ 
    * In the last 30 days two analysts negatively revised
earnings
estimates 
    * Bioventus Inc shares had risen by 27.0% this quarter and
lost 40.2% so far this year.
    * The company reported a quarterly loss of $7.25 million.
    * Wall Street's median 12-month price target for Bioventus
Inc is
$16.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data August 11
at 01:30 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2022      0.16           0.10           Missed
 Mar. 31 2022      0.05           0.04           Missed
 Dec. 31 2021      0.18           0.26           Beat
 Sep. 30 2021      0.14           0.25           Beat

Recent news on Bioventus

See all news